Putku et al. (39) reported several genetic variants in the promoter of CDH13 as meQTLs in hypertension patients (Table 1), several of them being also associated with high molecular weight adiponectin, a known ligand for CDH13, the binding of which results in increased proliferation and migration of endothelial cells (39). Here, CDH13 is linked to hypertensive disorder.